EGR1 and chronic myelogenous leukemia, BCR-ABL1 positive: Knockdown of Egr-1 in TKI-resistant CML cell lines was sufficient to decrease proliferation (Figure 3D) suggesting that Egr-1 plays an oncogenic role in CML.